stopwords, and 2-character and smaller words are excluded
Papers by T Hunter
Total: 1331, Nodes: 439, Word count: 3586, All words count: 5382
View: Overview. Sorted by percent.
Page 1 of 7: [ 1 2 3 4 5 6 7 ]
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 1 | PROTEIN | 84 | 19.1 | 222 | 10619
|
| 2 | KINASE | 78 | 17.8 | 202 | 11534
|
| 3 | PHOSPHORYLATION | 72 | 16.4 | 311 | 8688
|
| 4 | TYROSINE | 64 | 14.6 | 447 | 9924
|
| 5 | RECEPTOR | 42 | 9.6 | 151 | 6652
|
| 6 | PROTEIN-TYROSINE | 41 | 9.3 | 140 | 7351
|
| 7 | CELLS | 30 | 6.8 | 135 | 2698
|
| 8 | KINASES | 29 | 6.6 | 101 | 6710
|
| 9 | PROTEINS | 28 | 6.4 | 200 | 3927
|
| 10 | VIRUS | 27 | 6.2 | 354 | 4793
|
| 11 | ACTIVATION | 25 | 5.7 | 42 | 2691
|
| 12 | ACTIVITY | 24 | 5.5 | 112 | 4949
|
| 13 | CELL | 24 | 5.5 | 35 | 1800
|
| 14 | MURINE | 23 | 5.2 | 76 | 888
|
| 15 | PROTEIN-KINASE | 21 | 4.8 | 157 | 8005
|
| 16 | SUBSTRATE | 21 | 4.8 | 89 | 3369
|
| 17 | EXPRESSION | 20 | 4.6 | 78 | 1862
|
| 18 | INVITRO | 20 | 4.6 | 169 | 2419
|
| 19 | CHARACTERIZATION | 19 | 4.3 | 107 | 1560
|
| 20 | HUMAN | 19 | 4.3 | 96 | 3938
|
| 21 | REGULATION | 19 | 4.3 | 66 | 2809
|
| 22 | SIGNALING | 19 | 4.3 | 43 | 3375
|
| 23 | ROUS-SARCOMA | 18 | 4.1 | 366 | 4998
|
| 24 | DOMAIN | 17 | 3.9 | 27 | 1005
|
| 25 | GENE | 17 | 3.9 | 129 | 2167
|
| 26 | GROWTH | 16 | 3.6 | 41 | 1546
|
| 27 | IDENTIFICATION | 16 | 3.6 | 49 | 681
|
| 28 | TRANSFORMING | 16 | 3.6 | 154 | 3426
|
| 29 | ADHESION | 14 | 3.2 | 47 | 2217
|
| 30 | CELL-CYCLE | 14 | 3.2 | 53 | 2148
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 31 | EPIDERMAL | 14 | 3.2 | 100 | 2706
|
| 32 | PROTEIN-KINASES | 14 | 3.2 | 81 | 3728
|
| 33 | SITES | 14 | 3.2 | 42 | 2555
|
| 34 | FOCAL | 13 | 3.0 | 47 | 2211
|
| 35 | FUNCTION | 13 | 3.0 | 16 | 608
|
| 36 | NOVEL | 13 | 3.0 | 37 | 2251
|
| 37 | FACTOR | 12 | 2.7 | 24 | 1928
|
| 38 | GROWTH-FACTOR | 12 | 2.7 | 110 | 3537
|
| 39 | PEPTIDE | 12 | 2.7 | 24 | 530
|
| 40 | POLYOMA | 12 | 2.7 | 46 | 658
|
| 41 | ROLE | 12 | 2.7 | 18 | 451
|
| 42 | ANALYSIS | 11 | 2.5 | 73 | 1984
|
| 43 | CDK | 11 | 2.5 | 42 | 2686
|
| 44 | DNA | 11 | 2.5 | 12 | 670
|
| 45 | PHOSPHATASE | 11 | 2.5 | 22 | 397
|
| 46 | SARCOMA-VIRUS | 11 | 2.5 | 45 | 441
|
| 47 | SITE | 11 | 2.5 | 56 | 791
|
| 48 | TRANSCRIPTION | 11 | 2.5 | 24 | 3530
|
| 49 | CDC | 10 | 2.3 | 21 | 917
|
| 50 | CELLULAR | 10 | 2.3 | 96 | 1027
|
| 51 | EVIDENCE | 10 | 2.3 | 105 | 2418
|
| 52 | PHOSPHORYLATED | 10 | 2.3 | 44 | 865
|
| 53 | RAT | 10 | 2.3 | 13 | 598
|
| 54 | CYCLIN | 9 | 2.1 | 36 | 1546
|
| 55 | INVIVO | 9 | 2.1 | 105 | 1832
|
| 56 | LIGASE | 9 | 2.1 | 16 | 981
|
| 57 | NUCLEAR | 9 | 2.1 | 16 | 1108
|
| 58 | PHOSPHATASES | 9 | 2.1 | 17 | 2235
|
| 59 | PROTEIN-KINASE-C | 9 | 2.1 | 30 | 1884
|
| 60 | STRUCTURE | 9 | 2.1 | 7 | 321
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 61 | CYTOPLASMIC | 8 | 1.8 | 37 | 1175
|
| 62 | GENOME | 8 | 1.8 | 11 | 674
|
| 63 | INHIBITION | 8 | 1.8 | 23 | 455
|
| 64 | MITOTIC | 8 | 1.8 | 16 | 497
|
| 65 | MULTIPLE | 8 | 1.8 | 8 | 332
|
| 66 | PHOSPHORYLATES | 8 | 1.8 | 122 | 3259
|
| 67 | PP60C-SRC | 8 | 1.8 | 41 | 1076
|
| 68 | REQUIRED | 8 | 1.8 | 17 | 370
|
| 69 | SERINE | 8 | 1.8 | 9 | 480
|
| 70 | STRUCTURAL | 8 | 1.8 | 25 | 856
|
| 71 | TRANSCRIPTIONAL | 8 | 1.8 | 11 | 943
|
| 72 | TRANSFORMATION | 8 | 1.8 | 35 | 382
|
| 73 | TRANSFORMED | 8 | 1.8 | 45 | 463
|
| 74 | ALPHA | 7 | 1.6 | 9 | 215
|
| 75 | BINDING | 7 | 1.6 | 32 | 1494
|
| 76 | C-JUN | 7 | 1.6 | 12 | 2635
|
| 77 | CDNA | 7 | 1.6 | 33 | 1483
|
| 78 | CONTROL | 7 | 1.6 | 10 | 809
|
| 79 | CYCLIN-A | 7 | 1.6 | 41 | 1811
|
| 80 | DNA-SYNTHESIS | 7 | 1.6 | 13 | 229
|
| 81 | FIBROBLASTS | 7 | 1.6 | 24 | 389
|
| 82 | GROWTH-CONTROL | 7 | 1.6 | 8 | 95
|
| 83 | INHIBITOR | 7 | 1.6 | 26 | 2035
|
| 84 | MAJOR | 7 | 1.6 | 27 | 398
|
| 85 | MOLONEY | 7 | 1.6 | 32 | 390
|
| 86 | MOUSE | 7 | 1.6 | 13 | 544
|
| 87 | MUTANT | 7 | 1.6 | 13 | 208
|
| 88 | NATRIURETIC | 7 | 1.6 | 14 | 239
|
| 89 | POLYOMA-VIRUS | 7 | 1.6 | 20 | 247
|
| 90 | PROTEIN-PHOSPHORYLATION | 7 | 1.6 | 63 | 2436
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 91 | SRC | 7 | 1.6 | 124 | 813
|
| 92 | THREONINE | 7 | 1.6 | 33 | 1061
|
| 93 | TRANSLATION | 7 | 1.6 | 38 | 408
|
| 94 | ASSOCIATION | 6 | 1.4 | 8 | 351
|
| 95 | CALPACTIN-I | 6 | 1.4 | 10 | 580
|
| 96 | COMPLEXES | 6 | 1.4 | 15 | 443
|
| 97 | CYCLIN-B | 6 | 1.4 | 35 | 1680
|
| 98 | DEVELOPMENT | 6 | 1.4 | 4 | 60
|
| 99 | DNA-BINDING | 6 | 1.4 | 14 | 1717
|
| 100 | DOMAINS | 6 | 1.4 | 34 | 4035
|
| 101 | EARLY | 6 | 1.4 | 10 | 218
|
| 102 | ESSENTIAL | 6 | 1.4 | 55 | 1022
|
| 103 | GRB | 6 | 1.4 | 46 | 1658
|
| 104 | INDUCES | 6 | 1.4 | 50 | 2038
|
| 105 | INDUCTION | 6 | 1.4 | 3 | 261
|
| 106 | INFECTED | 6 | 1.4 | 18 | 197
|
| 107 | INTERACTION | 6 | 1.4 | 26 | 1242
|
| 108 | MAMMALIAN | 6 | 1.4 | 4 | 375
|
| 109 | MEDIATES | 6 | 1.4 | 8 | 218
|
| 110 | MESSENGER-RNA | 6 | 1.4 | 23 | 1012
|
| 111 | PLATELET-DERIVED | 6 | 1.4 | 44 | 1782
|
| 112 | PROLIFERATION | 6 | 1.4 | 2 | 127
|
| 113 | RECEPTORS | 6 | 1.4 | 8 | 955
|
| 114 | RECOGNITION | 6 | 1.4 | 16 | 960
|
| 115 | RNA | 6 | 1.4 | 18 | 119
|
| 116 | SEQUENCE | 6 | 1.4 | 27 | 909
|
| 117 | SER | 6 | 1.4 | 5 | 396
|
| 118 | SIGNAL | 6 | 1.4 | 15 | 916
|
| 119 | TYR | 6 | 1.4 | 41 | 972
|
| 120 | UBIQUITIN | 6 | 1.4 | 4 | 328
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 121 | YEAST | 6 | 1.4 | 14 | 465
|
| 122 | ADENOVIRUS | 5 | 1.1 | 28 | 741
|
| 123 | ANTIBODIES | 5 | 1.1 | 14 | 229
|
| 124 | ARREST | 5 | 1.1 | 5 | 158
|
| 125 | BETA | 5 | 1.1 | 2 | 142
|
| 126 | BUDDING | 5 | 1.1 | 11 | 415
|
| 127 | C-SRC | 5 | 1.1 | 13 | 410
|
| 128 | CASEIN | 5 | 1.1 | 4 | 680
|
| 129 | COMPLEX | 5 | 1.1 | 15 | 863
|
| 130 | CYCLIN-DEPENDENT | 5 | 1.1 | 18 | 428
|
| 131 | DALTON | 5 | 1.1 | 39 | 362
|
| 132 | DEPHOSPHORYLATION | 5 | 1.1 | 14 | 356
|
| 133 | DIMERIZATION | 5 | 1.1 | 13 | 327
|
| 134 | EBP | 5 | 1.1 | 2 | 142
|
| 135 | ERK | 5 | 1.1 | 13 | 719
|
| 136 | EXPRESSED | 5 | 1.1 | 22 | 364
|
| 137 | FUNCTIONAL | 5 | 1.1 | 7 | 288
|
| 138 | HYBRID | 5 | 1.1 | 10 | 98
|
| 139 | INCREASED | 5 | 1.1 | 7 | 445
|
| 140 | LOCALIZATION | 5 | 1.1 | 26 | 486
|
| 141 | MESSENGER-RNAS | 5 | 1.1 | 15 | 216
|
| 142 | MITOGEN-ACTIVATED | 5 | 1.1 | 12 | 733
|
| 143 | MUTATION | 5 | 1.1 | 12 | 231
|
| 144 | NETWORKS | 5 | 1.1 | 0 | 494
|
| 145 | NEURONAL | 5 | 1.1 | 0 | 254
|
| 146 | PATHWAYS | 5 | 1.1 | 15 | 1256
|
| 147 | PHOSPHOTYROSINE | 5 | 1.1 | 49 | 1422
|
| 148 | PIN | 5 | 1.1 | 9 | 277
|
| 149 | PLASMA-MEMBRANE | 5 | 1.1 | 36 | 670
|
| 150 | PRODUCT | 5 | 1.1 | 22 | 336
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 151 | PTP | 5 | 1.1 | 5 | 46
|
| 152 | RELATED | 5 | 1.1 | 25 | 1503
|
| 153 | SIGNAL-TRANSDUCTION | 5 | 1.1 | 32 | 2079
|
| 154 | T-ANTIGEN | 5 | 1.1 | 33 | 485
|
| 155 | T-ANTIGENS | 5 | 1.1 | 17 | 203
|
| 156 | TEMPERATURE-SENSITIVE | 5 | 1.1 | 19 | 182
|
| 157 | THR | 5 | 1.1 | 12 | 441
|
| 158 | TRKB | 5 | 1.1 | 13 | 1467
|
| 159 | UBIQUITINATION | 5 | 1.1 | 11 | 309
|
| 160 | VIRAL | 5 | 1.1 | 7 | 151
|
| 161 | VIVO | 5 | 1.1 | 13 | 310
|
| 162 | APOPTOSIS | 4 | 0.9 | 6 | 178
|
| 163 | AVIAN-SARCOMA | 4 | 0.9 | 10 | 75
|
| 164 | BRCA | 4 | 0.9 | 2 | 265
|
| 165 | CHAIN | 4 | 0.9 | 10 | 248
|
| 166 | CLONING | 4 | 0.9 | 7 | 375
|
| 167 | COMPARISON | 4 | 0.9 | 58 | 277
|
| 168 | CSF | 4 | 0.9 | 20 | 362
|
| 169 | DEPENDENT | 4 | 0.9 | 16 | 753
|
| 170 | DETECTION | 4 | 0.9 | 34 | 1477
|
| 171 | DICTYOSTELIUM | 4 | 0.9 | 5 | 46
|
| 172 | DISTINCT | 4 | 0.9 | 4 | 330
|
| 173 | DROSOPHILA | 4 | 0.9 | 4 | 41
|
| 174 | EUKARYOTIC | 4 | 0.9 | 10 | 1074
|
| 175 | FAMILY | 4 | 0.9 | 28 | 3980
|
| 176 | FORMS | 4 | 0.9 | 6 | 322
|
| 177 | HEAVY-CHAIN | 4 | 0.9 | 7 | 512
|
| 178 | HUMAN-CELLS | 4 | 0.9 | 10 | 299
|
| 179 | IN-VITRO | 4 | 0.9 | 11 | 137
|
| 180 | INDUCE | 4 | 0.9 | 48 | 404
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 181 | INDUCED | 4 | 0.9 | 8 | 335
|
| 182 | INHIBITORS | 4 | 0.9 | 12 | 1808
|
| 183 | INHIBITORY | 4 | 0.9 | 10 | 207
|
| 184 | INTEGRIN | 4 | 0.9 | 8 | 694
|
| 185 | INTRACELLULAR | 4 | 0.9 | 0 | 56
|
| 186 | INVOLVEMENT | 4 | 0.9 | 11 | 354
|
| 187 | ISOLATION | 4 | 0.9 | 21 | 978
|
| 188 | KINASE-C | 4 | 0.9 | 33 | 1039
|
| 189 | LAP | 4 | 0.9 | 6 | 364
|
| 190 | LOSS | 4 | 0.9 | 10 | 452
|
| 191 | MODULATION | 4 | 0.9 | 11 | 92
|
| 192 | N-TERMINAL | 4 | 0.9 | 2 | 420
|
| 193 | ONCOGENES | 4 | 0.9 | 1 | 970
|
| 194 | PHOSPHATASE-ALPHA | 4 | 0.9 | 13 | 257
|
| 195 | PHOSPHATIDYLINOSITOL | 4 | 0.9 | 6 | 268
|
| 196 | POTENTIAL | 4 | 0.9 | 3 | 26
|
| 197 | REGULATES | 4 | 0.9 | 5 | 202
|
| 198 | REPLICATION | 4 | 0.9 | 0 | 211
|
| 199 | REVEALS | 4 | 0.9 | 6 | 577
|
| 200 | ROLES | 4 | 0.9 | 2 | 41
|
Page 1 of 7: [ 1 2 3 4 5 6 7 ]